MedTrace Logo

The Impact of Patient Involvement in Decision-Making About Heart Disease Prevention

NCT00315978 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2007-07-10

No results posted yet for this study

Summary

The purpose of this study is to determine whether providing patients with information about their global coronary heart disease (CHD) risk and effective risk-reducing strategies allows them to make appropriate decisions about heart disease prevention.

Conditions

Interventions

DEVICE

Heart-to-Heart Decision Aid

Sponsors & Collaborators

  • University of North Carolina

    lead OTHER

Principal Investigators

  • Stacey L. Sheridan, MD, MPH · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-06-30
Completion
2004-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00315978 on ClinicalTrials.gov